Key result
Common genetic variants show no significant modification of thiazide-induced QT prolongation.
Why the study?
Thiazide diuretics may cause QT interval prolongation, a risk factor for fatal ventricular arrhythmias, and whether common single-nucleotide polymorphisms modify the association between thiazide use and the QT interval or its components was unknown.
Cohort (n=78,199)
Yes
Answers are grounded in this paper and cite their sources.
No common SNP modifiers of thiazide-QT effect identified; leaves open investigation of suggestive loci in larger studies.
Thiazide diuretics, commonly used antihypertensives, may cause QT interval (QT) prolongation, a risk factor for highly fatal and difficult to predict ventricular arrhythmias. We examined whether common single-nucleotide polymorphisms (SNPs) modified the association between thiazide use and QT or its component parts (QRS interval, JT interval) by performing ancestry-specific, trans-ethnic and cross-phenotype genome-wide analyses of European (66%), African American (15%) and Hispanic (19%) populations (N=78 199), leveraging longitudinal data, incorporating corrected standard errors to account for underestimation of interaction estimate variances and evaluating evidence for pathway enrichment. Although no loci achieved genome-wide significance (P<5 × 10 -8 m), we found suggestive evidence (P<5 × 10 -6 ) for SNPs modifying the thiazide-QT association at 22 loci, including ion transport loci (for example, NELL1, KCNQ3). The biologic plausibility of our suggestive results and simulations demonstrating modest power to detect interaction effects at genome-wide significant levels indicate that larger studies and innovative statistical methods are warranted in future efforts evaluating thiazide-SNP interactions.
No takes yet. Share an insight, caveat, or question.
Macfarlane et al. (2022) conducted a cohort in QT interval prolongation associated with thiazide diuretic use (n=78,199). Thiazide diuretic use and common single-nucleotide polymorphisms (SNPs) vs. Non-use of thiazide diuretics was evaluated on Modification of the association between thiazide use and QT interval (or QRS and JT intervals) by SNPs (p=<5 × 10^-6 (suggestive at 22 loci); no loci <5 × 10^-8). Common SNPs showed no genome-wide significant modification of the thiazide-QT association in 78,199 individuals, though 22 loci showed suggestive evidence.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: